Skip to main content
Molecules to Medicine

Molecules to Medicine

Demystifying drug development, clinical research, medicine, and the role ethics plays

Minnesota Attorney General Confirms They Did Not Exonerate UMN in Markingson Death

Minnesota Attorney General Confirms They Did Not Exonerate UMN in Markingson Death

Dan and his mom, Mary Weiss This research ethics series uses the story of Dan Markingson’s participation in a clinical trial of anti-psychotic drugs at the University of Minnesota, his suicide 2004 while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct.

June 14, 2013 — Judy Stone
Anti-Psychiatry Prejudice? A response to Dr. Lieberman

Anti-Psychiatry Prejudice? A response to Dr. Lieberman

  Facets of the field Kelly Hills (@rocza) was kind enough to call my attention to the guest post on SciAmMind by Jeffrey Lieberman, incoming president of the American Psychiatric Association (APA). Frankly, I'm appalled by Lieberman's post, especially as it was invited.

May 24, 2013 — Judy Stone
The s**t hits the fan - FDA, INDs, and fecal microbiota transplants

The s**t hits the fan - FDA, INDs, and fecal microbiota transplants

Bristol Stool Chart This weekend, the proverbial s**t hit the fan over the Food & Drug Administration's (FDA) decision to require an Investigational New Drug (IND) application for stool transplants—formally known as “fecal microbiota transplants (FMT)”—for the treatment of C.

May 20, 2013 — Judy Stone
How Not to Run an Op-Ed Page

How Not to Run an Op-Ed Page

  Editorial control On Mother’s Day, May 12, ethics Professor Carl Elliott had an Op-Ed published by the Minneapolis Star Tribune, “The University of Minnesota Research Case Needs Scrutiny.”  The Star Tribune began to post comments, the first being:Minnesoda73 May.

May 14, 2013 — Judy Stone
Yahrzeit - Reflections on Dan Markingson's Legacy

Yahrzeit - Reflections on Dan Markingson's Legacy

Angel of Grief This research ethics series uses the story of Dan Markingson’s participation in a clinical trial of anti-psychotic drugs at the University of Minnesota, his suicide 2004 while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct.

May 8, 2013 — Judy Stone
From Tel Aviv to Boston Bombings: Connections at TEDMED

From Tel Aviv to Boston Bombings: Connections at TEDMED

Roller coaster Of the roller coaster of emotions that has marked the past few weeks, personally and for the nation, one talk at TEDMED tied them all together for me, with the theme of our interdependence and how much we can accomplish if we work together.I’d like to share with you several seemingly unrelated events, with a commonality that crystallized for me at TEDMED.Preface: For me, this chapter started a little earlier, with a late night call that my daughter had fallen and was in an Emergency Room several hours from where I live.

April 30, 2013 — Judy Stone
A New University of Minnesota Mystery-The Curious Departure of Mark Rotenberg

A New University of Minnesota Mystery-The Curious Departure of Mark Rotenberg

All that is necessary for the triumph of evil is that good men do nothing. -Edmund Burke Hear no Evil One month ago, Mike Howard, family friend of Dan Markingson, who committed suicide while participating in a clinical trial at the UMN, launched a petition requesting that Governor Mark Dayton launch an independent investigation of research misconduct in the university’s psychiatry department.

April 11, 2013 — Judy Stone

Blog Index

Molecules to MedicineDemystifying drug development, clinical research, medicine, and the role ethics plays

Beyond XX and XY

Biology. Identity. Equality.